Article Details
Retrieved on: 2024-04-22 23:38:09
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses YS Biopharma Co.'s development of the YS-HBV-002 vaccine for chronic hepatitis B (HBV), highlighting its clinical trial approval in the Philippines and addressing the vaccine's potential impact on liver cancer prevention related to HBV.
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here